Trial intelligence / Profile preview

PECS and SAP Blocks for Analgesia in Minimally Invasive Cardiac Surgery

NCT03743194Phase 4Completed

Sponsor
Cleveland Clinic
Start
Dec 2021
Primary completion
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Cleveland Clinic. Primary endpoint: Overall Benefit Analgesia Score. Started Dec 2021; status: completed.

02

Drugs

liposomal bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03743194.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03743194.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call